Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
domingo, octubre 25
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Privia Health Group Inc
PRVA
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$22.41
-0.48
-2.08%
Últ. Act.: Oct 23, 4:00 PM
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Informe de acciones
Ganancias:
Beneficios de Q3 2026 dentro de 11 días de ahora en jue nov 5th, antes de la apertura del mercado
Privia Health Gr Financials
Privia Health Gr (PRVA) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
CORRECTION: Privia Health Gr Q2 Adj. EPS $0.19 Beats $0.07 Estimate, Sales $632.600M Beat $599.186M Estimate
Privia Health Gr (NASDAQ:PRVA) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $0.07 by 171.43 percent. This is a 11.76 percent increase over earnings of $0.17 per share from
Benzinga Newsdesk
PRO
Privia Health Gr Affirms FY2026 Sales Guidance of $2.350B-$2.450B vs $2.422B Est
Privia Health Gr (NASDAQ:PRVA) affirms FY2026 sales outlook from $2.350 billion-$2.450 billion to $2.350 billion-$2.450 billion vs $2.422 billion estimate.
Benzinga Newsdesk
PRO
Privia Health Gr Affirms FY2026 Sales Guidance of $2.350B-$2.450B vs $2.469B Est
Privia Health Gr (NASDAQ:PRVA) affirms FY2026 sales outlook from $2.350 billion-$2.450 billion to $2.350 billion-$2.450 billion vs $2.469 billion estimate.
Benzinga Newsdesk
PRO
Privia Health Gr Q1 Adj. EPS $0.19 Beats $0.07 Estimate, Sales $603.800M Beat $580.654M Estimate
Privia Health Gr (NASDAQ:PRVA) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $0.07 by 137.5 percent. This is a 18.75 percent increase over earnings of $0.16 per share from
Benzinga Newsdesk
Earnings Scheduled For February 26, 2026
Benzinga Insights
Privia Health Gr Earnings Report: Q4 Overview
Benzinga Insights
